Related references
Note: Only part of the references are listed.Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
Predrag Sikiric et al.
GUT AND LIVER (2020)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
Jaksa Vukojevic et al.
BRAIN AND BEHAVIOR (2020)
The Opening of Connexin 43 Hemichannels Alters Hippocampal Astrocyte Function and Neuronal Survival in Prenatally LPS-Exposed Adult Offspring
Carolina E. Chavez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
Jiajun Weng et al.
GENERAL PSYCHIATRY (2019)
Syk and Src-targeted anti-inflammatory activity of aripiprazole, an atypical antipsychotic
Sulgi Yoo et al.
BIOCHEMICAL PHARMACOLOGY (2018)
BPC157 as Potential Agent Rescuing from Cancer Cachexia
Eun A. Kang et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
Sven Seiwerth et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls
L. Garcia-Alvarez et al.
EUROPEAN PSYCHIATRY (2018)
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine
Domagoj Drmic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
Fedor Amic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Synthesis and biological evaluation of novel flavanone derivatives as potential antipsychotic agents
Hong-shun Gu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats
Dean Strinic et al.
LIFE SCIENCES (2017)
Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia
Karina S. MacDowell et al.
NEUROPHARMACOLOGY (2017)
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Antonija Duzel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
Domagoj Drmic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine
Zeljka Belosic Halle et al.
INFLAMMOPHARMACOLOGY (2017)
Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen
Maria Medvidovic-Grubisic et al.
INFLAMMOPHARMACOLOGY (2017)
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors
Andreia S. Cunha et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia
Nikolaos Pitsikas
CURRENT MEDICINAL CHEMISTRY (2016)
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs
Antonio Kokot et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats
Nermin Lojo et al.
PLOS ONE (2016)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Redox and Microglia in the Pathophysiology of Schizophrenia
Takahiro A. Kato et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2015)
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine
Mirjana Stupnisek et al.
PLOS ONE (2015)
BPC 157 and Blood Vessels
Sven Seiwerth et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Stable Gastric Pentadecapeptide BPC 157-NO-system Relation
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Profile of minocycline and its potential in the treatment of schizophrenia
Lulu Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
Bruna Mara Machado Ribeiro et al.
SCHIZOPHRENIA RESEARCH (2013)
N-methyl-D-aspartate receptor - nitric oxide synthase pathway in the cortex of Nogo-A-deficient rats in relation to brain laterality and schizophrenia
Zdena Kristofikova et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157
P. Sikiric et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Nitric oxide modulates apomorphine-induced recognition memory deficits in rats
Ioannis Gourgiotis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Nitric oxide modulates dopaminergic regulation of prepulse inhibition in the basolateial amygdala
C. Salum et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Revised Robert's Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production
Sabrina Ganzinelli et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Modulatio of Central Nitric Oxide as a Therapeutic Strategy for Schizophrenia
Marnie MacKay et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo
Stephen Sammut et al.
NEUROPHARMACOLOGY (2010)
Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels
Mahendra Bishnoi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons
Cristiane Salum et al.
BRAIN RESEARCH (2008)
The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production
Long Tai Zheng et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma
Qian Bian et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
The amphetamine-induced sensitized state as a model of schizophrenia
R. E. Featherstone et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia
Yechiel Levkovitz et al.
BRAIN RESEARCH (2007)
Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro
Takahiro Kato et al.
SCHIZOPHRENIA RESEARCH (2007)
Dopamine D2 receptor-dependent modulation of striatal NO synthase activity
Stephen Sammut et al.
PSYCHOPHARMACOLOGY (2007)
Mediation of glutamatergic receptors and nitric oxide on striatal doparnine release evoked by anatoxin-a.: An in vivo inicrodialysis study
Francisco Campos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat
C Salum et al.
PSYCHOPHARMACOLOGY (2006)
Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice
JGP Pires et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition
CV Tenn et al.
PSYCHOPHARMACOLOGY (2005)
(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia
JP Rung et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats
AB Blagaic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Role of nitric oxide on motor behavior
EA Del Bel et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain:: α-methyl-L-tryptophan autoradiographic measurements
Y Tohyama et al.
LIFE SCIENCES (2004)
Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats
MH Chan et al.
PSYCHOPHARMACOLOGY (2004)
Gender-related differences in the effects of nitric oxide donors on neuroleptic-induced catalepsy in mice
JGP Pires et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies
H Moore et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Role of nitric oxide in experimental models of psychosis in rats
M Gupta et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2001)
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice
I Bilic et al.
LIFE SCIENCES (2001)
Effects of nitric oxide synthase inhibitors on the discriminative stimulus effects of cocaine in rats
SL Collins et al.
PSYCHOPHARMACOLOGY (2001)
Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum
T Abekawa et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Carbachol inhibits Na+-K+-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway
DZ Ellis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors
CA Tieppo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
P Sikiric et al.
JOURNAL OF PHYSIOLOGY-PARIS (2000)
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157
P Sikiric et al.
JOURNAL OF PHYSIOLOGY-PARIS (2000)
Share Paper
